Anidulafungin versus fluconazole in the treatment of Candida albicans chorioretinitis.

Celia Ruiz-Arranz, Eugenio Pérez-Blázquez, Almudena De Pablo-Cabrera, Manuel Ferro-Osuna

Revista iberoamericana de micologia 2021 Oct-Dec

filter terms:

Candida albicans chorioretinitis is the most common cause of endogenous fungal endophthalmitis. Echinocandins are recommended as first-line therapy in the treatment of invasive candidiasis (IC), but in clinically stable patients with IC and endophthalmitis caused by Candida species susceptible to azole compounds these are the first-line treatment due to their better intraocular penetration. A 42-year-old woman admitted to hospital for duodenal perforation after gastrointestinal surgery and treated with broad-spectrum antibiotics developed C. albicans candidemia. According to protocol, an antifungal treatment with anidulafungin was given. The patient presented no visual symptoms but on routinary ophthalmoscopic examination multiple bilateral chorioretinal lesions were observed. Systemic therapy was changed to fluconazole, with good systemic and ocular results. Azole compounds are the first-line therapy for endophthalmitis associated with candidemia. However, clinical guidelines often propose echinocandins as the first option for IC. In some cases, C. albicans chorioretinitis will require a change in the systemic treatment to assure better intraocular penetration. According to the current evidence and our own experience, routine funduscopy is not necessary in all IC patients. However, we do recommend fundus examination in patients with visual symptoms or those unable to report them (paediatric patients and patients with an altered level of consciousness), and in those who are being treated with echinocandins in monotherapy. Copyright © 2021 Asociación Española de Micología. Publicado por Elsevier España, S.L.U. All rights reserved.

Citation

Celia Ruiz-Arranz, Eugenio Pérez-Blázquez, Almudena De Pablo-Cabrera, Manuel Ferro-Osuna. Anidulafungin versus fluconazole in the treatment of Candida albicans chorioretinitis. Revista iberoamericana de micologia. 2021 Oct-Dec;38(4):188-191